JNJ-42041935, HIF-PHD Inhibitor

Overview
Catalog #	bs-60285c-10mg-solid
Product Name	JNJ-42041935, HIF-PHD Inhibitor
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 346.65 Formula: C12 H6 Cl F3 N4 O3 CAS Number: 1193383-09-3 InChi Key: FXHHASJVTYRJHH-UHFFFAOYSA-N InChi: InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14,15)16)19-11(18-7)20-4-5(3-17-20)10(21)22/h1-4H,(H,18,19)(H,21,22) Smiles: OC(=O)C1C=NN(C=1)C1NC2C=C(OC(F)(F)F)C(Cl)=CC=2N=1 Purity: 98.0 Solubility: DMSO up to 100 mM Appearance: Solid Power. Shelf Life: 1.0 years
Description	JNJ-42041935 is a potent and selective HIF-PHD inhibitor. It is a 2-OG competitive and reversible inhibitor for PHD enzymes (pKis = 7.91, 7.29, and 7.65 for PHD1, 2, and 3, respectively). It is >100-fold selective for PHD compared to the related FIH (factor-inhibiting HIF) and a panel of various other enzymes. In an inflammation-induced anemia model in rats, 100 µM/kg/day JNJ-42041935 significantly increased the number of circulating reticulocytes and red blood cells, increased blood hemoglobin and hematocrit, and restored mean corpuscular volume and mean cell hemoglobin of red bloods cells. JNJ-42041935 is a new pharmacological tool, which can be used to investigate PHD inhibition and demonstrate that PHD inhibitors offer great promise for the treatment of inflammation-induced anemia.